Indication
Keratoconjunctivitis sicca
Keratoconjunctivitis sicca, commonly referred to as dry eye disease, is a multifactorial disorder affecting the ocular surface, tear film, and lacrimal functional unit. Read more about Keratoconjunctivitis sicca
14 drugs 13 manufacturers
Drugs that treat it
Common Keratoconjunctivitis sicca therapies.
CYCLOSPORINE
CYCLOSPORINE
CYCLOSPORINE
CYCLOSPORINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonKeratoconjunctivitis sicca, commonly referred to as dry eye disease, is a multifactorial disorder affecting the ocular surface, tear film, and lacrimal functional unit.
It predominantly affects adults, with an increased prevalence among older individuals, postmenopausal females, and patients with autoimmune conditions such as Sjögren disease.
Pathophysiologically, it is driven by tear hyperosmolarity and chronic immune-mediated ocular surface inflammation stemming from deficient aqueous tear production, excessive tear evaporation, or a combination of both.
Clinically, it manifests as tear film instability, ocular discomfort, foreign-body sensation, fluctuating visual acuity, and progressive epithelial damage across the cornea and conjunctiva.
- nih.gov
Keratoconjunctivitis sicca, commonly referred to as dry eye disease, is a multifactorial disorder affecting the ocular surface, tear film, and lacrimal functional unit Clinically, it manifests as tear film instability, ocular discomfort, foreign-body sensation, fluctuating visual acuity, and progressive epithelial damage across the cornea and conjunctiva
- nih.gov
Keratoconjunctivitis sicca, commonly referred to as dry eye disease, is a multifactorial disorder affecting the ocular surface, tear film, and lacrimal functional unit Pathophysiologically, it is driven by tear hyperosmolarity and chronic immune-mediated ocular surface inflammation stemming from deficient aqueous tear production, excessive tear evaporation, or a combination of both
- nih.gov
It predominantly affects adults, with an increased prevalence among older individuals, postmenopausal females, and patients with autoimmune conditions such as Sjögren disease
- nih.gov
It predominantly affects adults, with an increased prevalence among older individuals, postmenopausal females, and patients with autoimmune conditions such as Sjögren disease Pathophysiologically, it is driven by tear hyperosmolarity and chronic immune-mediated ocular surface inflammation stemming from deficient aqueous tear production, excessive tear evaporation, or a combination of both
- nih.gov
It predominantly affects adults, with an increased prevalence among older individuals, postmenopausal females, and patients with autoimmune conditions such as Sjögren disease
- nih.gov
Pathophysiologically, it is driven by tear hyperosmolarity and chronic immune-mediated ocular surface inflammation stemming from deficient aqueous tear production, excessive tear evaporation, or a combination of both Clinically, it manifests as tear film instability, ocular discomfort, foreign-body sensation, fluctuating visual acuity, and progressive epithelial damage across the cornea and conjunctiva
Personalize your experience
Follow Keratoconjunctivitis sicca and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.